Pharmaceutical & Medical
Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) has been closed on 07 May 2025. It no longer accepts any bids. For further information, you can contact the National Institutes of Health
Bellow, you can find more information about this project:
Location: United States
General information
National Institutes of Health
Pharmaceutical & Medical
Closed
Timeline
23 Feb 2022
07 May 2025
Not available
Contacts
Description
Receive Daily Tenders and Grants notifications
Subscribe nowFeatured tenders
-
, Asia Pacific Economic Cooperation, African Union, Central Bank of West African States - (APEC)03 copy.jpg)
Tender
25 Feb 2022
United States
Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)
National Institutes of Health
-
, Asia Pacific Economic Cooperation, African Union, Central Bank of West African States - (APEC)01 copy.jpg)
Tender
24 Feb 2022
United States
Notice of Intent to Publish a Funding Opportunity Announcement for Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
National Institutes of Health
-
Tender
28 Feb 2022
United States
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
![Addressing Conditions To Improve Population Health [ACTion]](https://storage.globaldatabase.com/storage/tender/covers_logo//22/Pharmaceutical & Medical Funding Opportunities from Asia Development Bank, European Union, Spanish Agency for International Development Cooperation (AECID) 04 copy.jpg)
Tender
01 Mar 2022
United States
Addressing Conditions To Improve Population Health [ACTion]
Centers for Disease Control - NCCDPHP
-
Tender
25 Feb 2022
United States
Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed)
National Institutes of Health
Get free access to our Tenders & Grants Database
Our service is free of charge and will always be
Join NowDonors
-
Agence Française de Développement (French Development Agency)
-
ASIAN INFRASTRUCTURE INVESTMENT BANK
-
DEPARTMENT FOR INTERNATIONAL DEVELOPMENT
-
EUROPEAN SECURITIES AND MARKETS AUTHORITY PROCUREMENT
-
INTER AMERICAN DEVELOPMENT BANK
-
KREDITANSTALT FUR WIEDERAUFBAU (RECONSTRUCTION CREDIT INSTITUTE)
-
NEW DEVELOPMENT BANK
-
ORGANIZATION OF AMERICAN STATES
-
UNITED NATIONS ENVIRONMENT PROGRAMME
-
UNITED NATIONS POPULATION FUND